CME GROUP ($CME) posted quarterly earnings results for Q4 2025 on Wednesday, February 4th. The company reported earnings of $2.77 per share, missing estimates of $2.77 by $0.00. The company also reported revenue of $1,648,700,000, missing estimates of $1,666,445,662 by $-17,745,662.
You can see Quiver Quantitative's $CME stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CME GROUP Insider Trading Activity
CME GROUP insiders have traded $CME stock on the open market 14 times in the past 6 months. Of those trades, 4 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:
- TERRENCE A DUFFY (Chairman and CEO) has made 0 purchases and 2 sales selling 25,000 shares for an estimated $6,738,815.
- SUNIL CUTINHO (Chief Information Officer) has made 0 purchases and 2 sales selling 11,896 shares for an estimated $3,229,444.
- DEREK SAMMANN (Sr MD Gl Hd Commodities Mkts) has made 0 purchases and 2 sales selling 7,200 shares for an estimated $1,984,798.
- HAROLD EUGENE JR. FORD sold 1,000 shares for an estimated $263,530
- JONATHAN L MARCUS (Sr MD General Counsel) has made 0 purchases and 2 sales selling 768 shares for an estimated $200,072.
- WILLIAM R SHEPARD has made 4 purchases buying 536 shares for an estimated $145,679 and 0 sales.
- TIMOTHY FRANCIS MCCOURT (Sr MD Global Head Equity & FX) sold 379 shares for an estimated $98,475
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CME GROUP Hedge Fund Activity
We have seen 832 institutional investors add shares of CME GROUP stock to their portfolio, and 729 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SANDERS CAPITAL, LLC added 3,726,755 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,006,931,933
- JPMORGAN CHASE & CO removed 2,744,851 shares (-22.3%) from their portfolio in Q3 2025, for an estimated $741,631,291
- STRIVE ASSET MANAGEMENT, LLC added 2,355,701 shares (+inf%) to their portfolio in Q3 2025, for an estimated $636,486,853
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,998,425 shares (+63.5%) to their portfolio in Q3 2025, for an estimated $539,954,450
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,605,469 shares (+27.9%) to their portfolio in Q3 2025, for an estimated $433,781,669
- BLACKROCK, INC. added 1,222,646 shares (+4.1%) to their portfolio in Q3 2025, for an estimated $330,346,722
- UBS GROUP AG removed 1,017,014 shares (-35.1%) from their portfolio in Q4 2025, for an estimated $277,726,183
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CME GROUP Congressional Stock Trading
Members of Congress have traded $CME stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 4 times. They made 1 purchase worth up to $15,000 on 08/11 and 3 sales worth up to $45,000 on 12/18, 11/13, 08/14.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CME GROUP Analyst Ratings
Wall Street analysts have issued reports on $CME in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 11/13/2025
- Deutsche Bank issued a "Buy" rating on 10/23/2025
- Morgan Stanley issued a "Overweight" rating on 10/23/2025
- Citigroup issued a "Buy" rating on 09/25/2025
- JP Morgan issued a "Underweight" rating on 09/25/2025
To track analyst ratings and price targets for CME GROUP, check out Quiver Quantitative's $CME forecast page.
CME GROUP Price Targets
Multiple analysts have issued price targets for $CME recently. We have seen 10 analysts offer price targets for $CME in the last 6 months, with a median target of $304.5.
Here are some recent targets:
- Michael Cyprys from Morgan Stanley set a target price of $319.0 on 01/15/2026
- Bill Katz from TD Cowen set a target price of $305.0 on 01/14/2026
- Benjamin Budish from Barclays set a target price of $304.0 on 12/12/2025
- Patrick Moley from Piper Sandler set a target price of $313.0 on 11/13/2025
- Alex Kramm from UBS set a target price of $280.0 on 10/23/2025
- Brian Bedell from Deutsche Bank set a target price of $300.0 on 10/23/2025
- Patrick O'Shaughnessy from Raymond James set a target price of $307.0 on 10/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
